
- Pharmaceutical Technology-05-15-2020
- Volume 2020 eBook
- Issue 2
Complications in Process Simulation Execution
Regulators have exaggerated expectations for simulated media fills.
Regulators have exaggerated expectations for simulated media fills.
This article reviews aspects of media fill execution in which regulatory expectations have created artificial compliance concerns and significant practical difficulties.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14, 43
Citation
When referring to this article, please cite it as J. Agalloco, "Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).
Articles in this issue
about 6 years ago
On Point: Biologics Drive Growth in Pre-Filled Syringesabout 6 years ago
Instrumenting Single-Use Processesabout 6 years ago
Considerations in Contamination Controlabout 6 years ago
Best systems and equipment for contamination controlabout 6 years ago
Building Data Quality In Generates Quality Data Outabout 6 years ago
Detecting Contamination in Cell Therapiesabout 6 years ago
Optimizing Viral Vector Manufacturing for Gene Therapyabout 6 years ago
Minimizing Contamination During Biopharma R&D



